Get the app!
Back to Trades

Burshtein Gregory

Chief of R&DCIK 0002026002

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Burshtein Gregory, Chief of R&D, accounts for 2 disclosed filings worth $456.0K, all concentrated in Entera Bio Ltd. (ENTX), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
May 8ENTX
Entera Bio Ltd.
Burshtein GregoryChief of R&DGrant$0
Jul 18ENTX
Entera Bio Ltd.
Burshtein GregoryChief of R&DGrant$456.0K

2 filings